APO Research
Talk to an analyst

APO RESEARCH · REPORT

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)

Compare research editions
View pricing & licenses

Selected research

Industry Research

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Research Report 2026

28 December 2025124 pages

Choose your research edition.

Industry ResearchGranulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) include Nobelpharma, Partner Therapeutics, Guangzhou Baiyunshan Pharmaceutical, Harbin Pharmaceutical Group, Hainan Unipul Pharmaceutical, North China Pharmaceutical, Amoytop Biotech and Changchun GeneScience Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market by Company

Nobelpharma

Partner Therapeutics

Guangzhou Baiyunshan Pharmaceutical

Harbin Pharmaceutical Group

Hainan Unipul Pharmaceutical

North China Pharmaceutical

Amoytop Biotech

Changchun GeneScience Pharmaceutical

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Segment by Type

Injection

Inhalation

Other

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Segment by Application

Cancer Treatment Support

Infectious Disease Treatment

Proteinosis Autoimmune Pulmonary Alveolar

Other

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Manufacturers (2021-2026) Table 8. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue of Manufacturers (2021-2026) Table 9. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Product Type & Application Table 14. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Nobelpharma Company Information Table 19. Nobelpharma Business Overview Table 20. Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 22. Nobelpharma Recent Developments Table 23. Partner Therapeutics Company Information Table 24. Partner Therapeutics Business Overview Table 25. Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 27. Partner Therapeutics Recent Developments Table 28. Guangzhou Baiyunshan Pharmaceutical Company Information Table 29. Guangzhou Baiyunshan Pharmaceutical Business Overview Table 30. Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 32. Guangzhou Baiyunshan Pharmaceutical Recent Developments Table 33. Harbin Pharmaceutical Group Company Information Table 34. Harbin Pharmaceutical Group Business Overview Table 35. Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 37. Harbin Pharmaceutical Group Recent Developments Table 38. Hainan Unipul Pharmaceutical Company Information Table 39. Hainan Unipul Pharmaceutical Business Overview Table 40. Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 42. Hainan Unipul Pharmaceutical Recent Developments Table 43. North China Pharmaceutical Company Information Table 44. North China Pharmaceutical Business Overview Table 45. North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 47. North China Pharmaceutical Recent Developments Table 48. Amoytop Biotech Company Information Table 49. Amoytop Biotech Business Overview Table 50. Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 52. Amoytop Biotech Recent Developments Table 53. Changchun GeneScience Pharmaceutical Company Information Table 54. Changchun GeneScience Pharmaceutical Business Overview Table 55. Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 57. Changchun GeneScience Pharmaceutical Recent Developments Table 58. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 59. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (2021-2026) & (K Units) Table 60. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Region (2021-2026) Table 61. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (2027-2032) & (K Units) Table 62. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Region (2027-2032) Table 63. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Region (2021-2026) Table 65. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Region (2027-2032) Table 67. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 68. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2026) & (K Units) Table 69. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2027-2032) & (K Units) Table 70. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2021-2026) & (US$ Million) Table 71. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2027-2032) & (US$ Million) Table 72. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2026) & (K Units) Table 74. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2027-2032) & (K Units) Table 75. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2021-2026) & (US$ Million) Table 76. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2027-2032) & (US$ Million) Table 77. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2026) & (K Units) Table 79. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2027-2032) & (K Units) Table 80. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2021-2026) & (US$ Million) Table 81. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2027-2032) & (US$ Million) Table 82. South America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. South America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2026) & (K Units) Table 84. South America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2027-2032) & (K Units) Table 85. South America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2021-2026) & (US$ Million) Table 86. South America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2027-2032) & (US$ Million) Table 87. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2026) & (K Units) Table 89. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2027-2032) & (K Units) Table 90. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2021-2026) & (US$ Million) Table 91. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2027-2032) & (US$ Million) Table 92. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2026) & (K Units) Table 93. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2027-2032) & (K Units) Table 94. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Type (2021-2026) Table 95. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Type (2027-2032) Table 96. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2021-2026) & (US$ Million) Table 97. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2027-2032) & (US$ Million) Table 98. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Type (2021-2026) Table 99. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Type (2027-2032) Table 100. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Type (2021-2026) & (US$/Unit) Table 101. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Type (2027-2032) & (US$/Unit) Table 102. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2026) & (K Units) Table 103. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2027-2032) & (K Units) Table 104. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Application (2021-2026) Table 105. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Application (2027-2032) Table 106. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2021-2026) & (US$ Million) Table 107. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2027-2032) & (US$ Million) Table 108. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Application (2021-2026) Table 109. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Application (2027-2032) Table 110. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Application (2021-2026) & (US$/Unit) Table 111. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Application (2027-2032) & (US$/Unit) Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Distributors List Table 115. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Customers List Table 116. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Trends Table 117. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Drivers Table 118. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Restraints Table 119. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Image Figure 5. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size (2021-2032) & (US$ Million) Figure 7. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (2021-2032) & (K Units) Figure 8. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Average Price (US$/Unit) & (2021-2032) Figure 9. Injection Product Image Figure 10. Inhalation Product Image Figure 11. Other Product Image Figure 12. Cancer Treatment Support Product Image Figure 13. Infectious Disease Treatment Product Image Figure 14. Proteinosis Autoimmune Pulmonary Alveolar Product Image Figure 15. Other Product Image Figure 16. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region in 2025 Figure 22. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region in 2025 Figure 23. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country in 2025 Figure 24. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2021-2032) Figure 25. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Country (2021-2032) Figure 26. United States Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country in 2025 Figure 30. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2021-2032) Figure 31. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Country (2021-2032) Figure 32. Germany Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country in 2025 Figure 43. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Country (2021-2032) Figure 45. China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country in 2025 Figure 54. South America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2021-2032) Figure 55. South America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Country (2021-2032) Figure 56. Brazil Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Colombia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country in 2025 Figure 61. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Country (2021-2032) Figure 63. Egypt Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Type (2021-2032) Figure 69. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Type (2021-2032) Figure 70. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price (US$/Unit) by Type (2021-2032) Figure 71. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Application (2021-2032) Figure 72. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Application (2021-2032) Figure 73. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price (US$/Unit) by Application (2021-2032) Figure 74. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Value Chain Figure 75. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Opportunities and Challenges

Scope & coverage.

Types
  • Injection
  • Inhalation
  • Other
Applications
  • Cancer Treatment Support
  • Infectious Disease Treatment
  • Proteinosis Autoimmune Pulmonary Alveolar
  • Other
Companies covered
  • Nobelpharma
  • Partner Therapeutics
  • Guangzhou Baiyunshan Pharmaceutical
  • Harbin Pharmaceutical Group
  • Hainan Unipul Pharmaceutical
  • North China Pharmaceutical
  • Amoytop Biotech
  • Changchun GeneScience Pharmaceutical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size (2021-2032)
  4. 2.2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (2021-2032)
  5. 2.2.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Average Price (2021-2032)
  6. 2.3 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Injection
  9. 2.3.3 Inhalation
  10. 2.3.4 Other
  11. 2.4 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Cancer Treatment Support
  14. 2.4.3 Infectious Disease Treatment
  15. 2.4.4 Proteinosis Autoimmune Pulmonary Alveolar
  16. 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Product Type & Application
  8. 3.8 Global Manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Established Date
  9. 3.9 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Nobelpharma
  2. 4.1.1 Nobelpharma Company Information
  3. 4.1.2 Nobelpharma Business Overview
  4. 4.1.3 Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  6. 4.1.5 Nobelpharma Recent Developments
  7. 4.2 Partner Therapeutics
  8. 4.2.1 Partner Therapeutics Company Information
  9. 4.2.2 Partner Therapeutics Business Overview
  10. 4.2.3 Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  12. 4.2.5 Partner Therapeutics Recent Developments
  13. 4.3 Guangzhou Baiyunshan Pharmaceutical
  14. 4.3.1 Guangzhou Baiyunshan Pharmaceutical Company Information
  15. 4.3.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
  16. 4.3.3 Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  18. 4.3.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
  19. 4.4 Harbin Pharmaceutical Group
  20. 4.4.1 Harbin Pharmaceutical Group Company Information
  21. 4.4.2 Harbin Pharmaceutical Group Business Overview
  22. 4.4.3 Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  24. 4.4.5 Harbin Pharmaceutical Group Recent Developments
  25. 4.5 Hainan Unipul Pharmaceutical
  26. 4.5.1 Hainan Unipul Pharmaceutical Company Information
  27. 4.5.2 Hainan Unipul Pharmaceutical Business Overview
  28. 4.5.3 Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  30. 4.5.5 Hainan Unipul Pharmaceutical Recent Developments
  31. 4.6 North China Pharmaceutical
  32. 4.6.1 North China Pharmaceutical Company Information
  33. 4.6.2 North China Pharmaceutical Business Overview
  34. 4.6.3 North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  36. 4.6.5 North China Pharmaceutical Recent Developments
  37. 4.7 Amoytop Biotech
  38. 4.7.1 Amoytop Biotech Company Information
  39. 4.7.2 Amoytop Biotech Business Overview
  40. 4.7.3 Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  42. 4.7.5 Amoytop Biotech Recent Developments
  43. 4.8 Changchun GeneScience Pharmaceutical
  44. 4.8.1 Changchun GeneScience Pharmaceutical Company Information
  45. 4.8.2 Changchun GeneScience Pharmaceutical Business Overview
  46. 4.8.3 Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  48. 4.8.5 Changchun GeneScience Pharmaceutical Recent Developments
5 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Scenario by Region
  1. 5.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region: 2021-2032
  3. 5.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region: 2021-2026
  4. 5.2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region: 2027-2032
  5. 5.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region: 2021-2032
  6. 5.3.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region: 2021-2026
  7. 5.3.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region: 2027-2032
  8. 5.4 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Facts & Figures by Country
  9. 5.4.1 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2032)
  11. 5.4.3 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Facts & Figures by Country
  16. 5.5.1 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2032)
  18. 5.5.3 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Facts & Figures by Country
  41. 5.7.1 South America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2032)
  43. 5.7.3 South America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2032)
  2. 6.1.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Type (2021-2032)
  4. 6.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2021-2032)
  5. 6.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2032)
  2. 7.1.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Application (2021-2032)
  4. 7.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2021-2032)
  5. 7.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Value Chain Analysis
  2. 8.1.1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Production Mode & Process
  5. 8.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Distributors
  8. 8.2.3 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Customers
9 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Analyzing Market Dynamics
  1. 9.1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Trends
  2. 9.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Drivers
  3. 9.3 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Opportunities and Challenges
  4. 9.4 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst